Tag: Pharnext
Pharnext: Expressions of interest received, the title soars
(CercleFinance.com) – The biopharmaceutical company Pharnext is trading on the Paris Stock Exchange this Wednesday after receiving several expressions of interest with a view to signing a possible licensing agreement.…
PHARNEXT: Information relating to the total number of voting rights and shares making up the share capital and the nominal value of the shares – 09/06/2023 at 6:00 p.m.
PARIS, France, SEPTEMBER 6, 2023 at 6 p.m. (CET) – Pharnext SCA (FR001400GUN7 – ALPHA) (the “Company”), a biopharmaceutical company at an advanced clinical stage developing new therapies for neurodegenerative…
PHARNEXT: PHARNEXT: Fundraising of 0.5 million euros – 2023-08-29 at 20:00
PARIS, France, August 29, 2023 at 6 p.m. (CET) – Pharnext SCA (FR001400GUN7 – ALPHA) (the “Company”), a late-stage biopharmaceutical company developing new therapies for neurodegenerative diseases with no satisfactory…
Pharnext: Phase III trial completed on time – 08/24/2023 at 10:17 am
(CercleFinance.com) – Pharnext announced on Thursday that it has completed its pivotal phase III clinical study in Charcot-Marie-Tooth disease type A (CMT1A) on time. In a press release, the biopharmaceutical…
PHARNEXT: Information relating to the total number of voting rights and shares making up the share capital and the nominal value of the shares – 08/01/2023 at 7:00 p.m.
PARIS, France, 1 er August 2023 at 7 p.m. (CET) – Pharnext SCA (FR001400GUN7 – ALPHA) (the “Company”), a biopharmaceutical company at an advanced clinical stage developing new therapies for…
Pharnext: new fundraising of 1 ME
By Alexandra Saintpierre Published on 07/13/2023 at 7:50 p.m. Photo credit © CrostaPics (Boursier.com) — The biopharmaceutical company…
PHARNEXT: Fundraising of 1 million euros – 2023-07-13 at 18:00
PARIS, France, July 13, 2023 at 6 p.m. (CET) – Pharnext SCA (FR001400GUN7 – ALPHA) (the “Company”), a late-stage biopharmaceutical company developing new therapies for neurodegenerative diseases with no satisfactory…
Pharnext: raises 1ME by issuing OCEANE-BSA bonds – 07/13/2023 at 6:10 p.m.
(CercleFinance.com) – Pharnext announces a fundraising of one million euros through the issue of OCEANE-BSA bonds, with a nominal value of €1,000,000, subscribed by Global Tech Opportunities 13. The issue…
Pharnext announces a fundraising of 1 million euros – 07/13/2023 at 18:16
(AOF) – Pharnext announces a fundraising of one million euros through the issuance of Oceane-BSA, with a nominal value of 1 million euros, subscribed by Global Tech Opportunities 13. Biotech…
Pharnext: raises 1ME by issuing OCEANE-BSA bonds
(CercleFinance.com) – Pharnext announces a fundraising of one million euros through the issue of OCEANE-BSA bonds, with a nominal value of €1,000,000, subscribed by Global Tech Opportunities 13. The issue…
Pharnext: Shareholders approve the appointment of Guy-Charles Fanneau de La Horie to the Supervisory Board
By Hector Chaunu Published on 07/10/2023 at 08:47 Photo credit © ChaunuPictures (Boursier.com) — Pharnext a biopharmaceutical company…
PHARNEXT: Reduction of the par value of the share – 2023-07-06 at 20:00
PARIS, France, July 6, 2023 at 8:00 p.m. (CET) – Pharnext SA (FR001400GUN7 – ALPHA) (the “Company”), a late-stage biopharmaceutical company developing novel therapies for neurodegenerative diseases with no satisfactory…